The estimated Net Worth of Jeffrey A Graves is at least 2.76 百万$ dollars as of 25 November 2022. Dr Graves owns over 20,000 units of 3D Systems stock worth over 1,246,506$ and over the last 21 years he sold DDD stock worth over 602,754$. In addition, he makes 910,848$ as Pres、 CEO & Director at 3D Systems.
Sign up
Dr Graves DDD stock SEC Form 4 insiders trading
Dr has made over 25 trades of the 3D Systems stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of DDD stock worth 192,000$ on 25 November 2022.
The largest trade he's ever made was selling 40,837 units of 3D Systems stock on 9 March 2022 worth over 602,754$. On average, Dr trades about 1,022 units every 17 days since 2003. As of 25 November 2022 he still owns at least 569,181 units of 3D Systems stock.
You can see the complete history of Dr Graves stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Jeffrey A. Graves biography
Dr. Jeffrey A. Graves is the Pres, CEO & Director at 3D Systems.
What is the salary of Dr Graves?
As the Pres、 CEO & Director of 3D Systems, the total compensation of Dr Graves at 3D Systems is 910,848$. There are 2 executives at 3D Systems getting paid more, with Herbert Koeck having the highest compensation of 1,443,180$.
How old is Dr Graves?
Dr Graves is 60, he's been the Pres、 CEO & Director of 3D Systems since . There are 9 older and 17 younger executives at 3D Systems. The oldest executive at 3D Systems Corp. is Dr. Charles W. Hull, 81, who is the Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director.
What's Dr Graves's mailing address?
Jeffrey's mailing address filed with the SEC is 333, Three D Systems Circle, Rock Hill, York County, South Carolina, 29730, United States.
Insiders trading at 3D Systems
Over the last 14 years, insiders at 3D Systems have traded over 140,581,615$ worth of 3D Systems stock and bought 532,605 units worth 6,075,291$ . The most active insiders traders include G Walter Ii Loewenbaum、Abraham N Reichental、Vyomesh Joshi. On average, 3D Systems executives and independent directors trade stock every 25 days with the average trade being worth of 60,930$. The most recent stock trade was executed by Thomas W Erickson on 28 November 2023, trading 50,000 units of DDD stock currently worth 265,000$.
What does 3D Systems do?
3d systems provides the most advanced and comprehensive 3d digital design and fabrication solutions available today, including 3d printers, print materials and cloud-sourced custom parts. its powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using its vast material selection, including plastics, metals, ceramics and edibles. 3ds’ leading personalized medicine capabilities save lives and include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. its democratized 3d digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. 3ds’ products and services disrupt traditional methods, deliver improved results and empower its customers to manufacture the future now.
What does 3D Systems's logo look like?
Complete history of Dr Graves stock trades at Faro Technologies、Integra Lifesciences Corp、MTS Systems、3D Systems、Hexcel、KraneShares Trust、Teleflex
3D Systems executives and stock owners
3D Systems executives and other stock owners filed with the SEC include:
-
Herbert Koeck,
Executive Vice President, Global Go To Market -
Andrew Johnson,
Executive Vice President, Chief Legal Officer and Secretary -
Dr. Jeffrey A. Graves,
Pres, CEO & Director -
Reji Puthenveetil,
Exec. VP of Industrial Solutions -
Charles Hull,
Chief Technology Officer, Executive Vice President, Director -
Menno Ellis,
Exec. VP of Healthcare Solutions -
Andrew Martin Johnson,
Exec. VP, Chief Legal Officer & Sec. -
Charles McClure,
Independent Chairman of the Board -
Thomas Erickson,
Independent Director -
William Curran,
Independent Director -
Kevin Moore,
Independent Director -
John Tracy,
Independent Director -
William Humes,
Independent Director -
Jeffrey Wadsworth,
Independent Director -
Jimmy Kever,
Independent Director -
Malissia Clinton,
Independent Director -
Anthony Grabenau,
Principal Accounting Officer -
Sadie Stern,
Executive Vice President - People and Culture -
Reji Puthenveetil,
Executive Vice President - Industrial Solutions -
Radhika Krishnan,
Executive Vice President - Software and Healthcare -
Menno Ellis,
Executive Vice President - Healthcare Solutions -
Jagtar Narula,
Chief Financial Officer, Executive Vice President -
Jeffrey Graves,
President, Chief Executive Officer, Executive Director -
Phyllis B. Nordstrom,
Exec. VP, Chief People & Culture Officer and Chief Compliance Officer -
John E. Nypaver Jr.,
VP of Investor Relations & Treasurer -
Dr. Brent Stucker Ph.D.,
Chief Scientist -
Michael S. Crimmins,
Sr. VP & Chief Accounting Officer -
Dr. Charles W. Hull,
Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director -
Jeff Blank,
Exec. VP of Engineering & Product Devel. -
Allen Latty,
Sr. VP of People & Culture -
Anthony J. Grabenau,
VP, Global Corp. Controller & Principal Accounting Officer -
Jagtar Narula,
Exec. VP & CFO -
Jeffrey D Creech,
EVP & CFO -
Jim D Kever,
Director -
John N Mc Mullen,
EVP & CFO -
Kevin Mcalea,
Vice President -
G Walter Ii Loewenbaum,
Director -
Karen E Welke,
Director -
Mark William Wright,
EVP & COO -
Vyomesh Joshi,
President and CEO -
Cathy L Lewis,
Vice President -
Riper Daniel S Van,
Director -
Andrew William Banasick Wright,
SVP, GC & Secretary -
Vasant Padmanabhan,
Director -
Joseph R. Zuiker,
EVP, Engineering & Operations -
Philip C. Schultz,
EVP, Operations -
Theodore A Hull,
EVP & CFO on 11-11-2014 -
Abraham N Reichental,
President and CEO -
Peter Diamandis,
Director -
David Robert Styka,
VP & Chief Accounting Officer -
Damon Joseph Gregoire,
VP, Chief Financial Officer -
Robert M Jr Grace,
VP, General Counsel & Secretar -
Todd Booth,
EVP & Chief Financial Officer -
Michael S Crimmins,
Former SVP and CAO -
Wayne C Pensky,
Interim CFO -
Jeff Blank,
EVP, Engineering and Prod Dev -
David K Leigh,
EVP & CTO (Additive Mfg) -
Phyllis B Nordstrom,
EVP & CHRO -
Claudia Drayton,
Director -
Michael Lynn Turner,
-
Harriss T Currie,
President, Regenerative Med -
Margaret E Wicklund,
Chief Accounting Officer